Lexicon Pharma (LXRX) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.37 +2.16%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $234 thousand, versus $9.16 million reported last year.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
